INTRODUCTION
Cell division requires the precise coordination of a number of events. The passenger proteins, described for the first time more than a decade ago (Earnshaw and Bernat, 1991) , are involved in two such events: chromosome segregation and cytokinesis. However, the role of these proteins is still poorly understood (for review, see Adams et al., 2001a) . All passenger proteins exhibit a specific distribution pattern during mitosis. At metaphase, they associate with inner centromeres and upon the transition to anaphase, they translocate to the spindle midzone and finally localize to the midbody during cell cleavage. To date, several different passenger proteins have been identified: INCENP (Cooke et al., 1987) , survivin (Skoufias et al., 2000) , TD60 (Andreassen et al., 1991; Martineau-Thuillier et al., 1998) , ORC6 (Prasanth et al., 2002) , Borealin/Dasra B (Gassmann et al., 2004; Sampath et al., 2004) , and Aurora B (Adams et al., 2000) . In both Caenorhabditis elegans and Drosophila, depletion by RNA interference (RNAi) of one of the passenger proteins, either INCENP, survivin, or Aurora B, results in mislocalization and redistribution of the other passenger proteins (Kaitna et al., 2000; Speliotes et al., 2000; Adams et al., 2001b) . Similar results have been obtained in mammalian cells (Mollinari et al., 2003) . Biochemical studies have demonstrated that INCENP, survivin, Dasra B, and Aurora B exist as a complex in extracts isolated from Xenopus eggs (Adams et al., 2000; Bolton et al., 2002) . In vitro experiments have shown that survivin interacts directly with both INCENP and Aurora B (Adams et al., 2000; Wheatley et al., 2001) . Aurora A, a paralogue of Aurora B, is a mitotic serinethreonine kinase that exhibits localization and activity that are distinct from Aurora B (Bischoff and Plowman, 1999; Giet and Prigent, 1999) . Whereas Aurora B is a passenger protein with a role in chromosome segregation and cell cleavage, Aurora A has a role in centrosome function (Nigg, 2002) . The two proteins seem to have derived from a single progenitor, Ipl1, present in yeast (Bischoff and Plowman, 1999) . Genetic analysis of the single Aurora kinase Ipl1 in Saccharomyces cerevisiae has suggested that Ipl1 is involved in chromosome segregation (Chan and Botstein, 1993; Biggins et al., 1999) , and recent reports offer evidence that Ipl1 is required to monitor tension at kinetochores (Biggins and Murray, 2001; Stern and Murray, 2001; Tanaka et al., 2002) .
Although the central catalytic domains of Aurora A and Aurora B share substantial homology, the N terminus of the two proteins is highly divergent, and it would be reasonable to assume that the divergent sequences relate to the highly divergent functions of the two proteins.
The difference of function between the two proteins has been made evident by RNAi ablation. In C. elegans embryos, Aurora B is involved in chromosome segregation, midbody organization, polar body extrusion, completion of cytokinesis, and histone H3 phosphorylation (Schumacher et al., 1998; Speliotes et al., 2000) . In Drosophila, Aurora B plays multiple roles in cell division, being involved in metaphase chromosome alignment, kinetochore disjunction, chromosome segregation, and histone H3 phosphorylation (Adams et al., 2001b; Giet and Glover, 2001 ).
In contrast, Aurora A, does not localize to inner centromeres or the cleavage furrow, but associates with the microtubule binding protein TPX2 (Kufer et al., 2002) and is associated with the centrosome and mitotic spindle during mitosis (Bischoff et al., 1998; Zhou et al., 1998; Kufer et al., 2002) . Aurora A is required for centrosome maturation and formation of a bipolar mitotic spindle (Hannak et al., 2001) , for mitotic checkpoint function (Anand et al., 2003) , and for accurate segregation of both centrosomes and chromosomes into daughter cells during mitotic exit (Bischoff and Plowman, 1999; Dutertre et al., 2002; Meraldi et al., 2002) .
Despite the high interest in their functions, there is little information on the sequence requirements for the distinct targeting and functions of Auroras A and B. In this work, we have used a combination of small interfering RNA (siRNA) (Elbashir et al., 2001; Brummelkamp et al., 2002) depletion of Aurora B and restoration of function with Aurora B truncation mutants to determine the domain requirements for Aurora B function in mammalian cells in culture. We here report that a short C-terminal sequence of Aurora B is required for localization to the inner centromeres at metaphase and for Aurora B function.
MATERIALS AND METHODS

Plasmid Constructions
pcDNA-HA Aurora-B and pcDNA-HA Amino-Terminal Deletion Aurora Constructs. The full-length Aurora B sequence was polymerase chain reaction (PCR)-amplified from human fetal liver Marathon-ready cDNA by using the forward AurB(ϩ) 5Ј-cgcggatccgcccagaaggagaactcctac-3Ј and the reverse AurB(Ϫ) 5Ј-ccgccgctcgagggccgacagattgaagggc-3Ј oligonucleotides. Aminoterminal deletions of Aurora B were constructed by PCR amplification by using the following three forward oligonucleotides: 5Ј-cgcggatccggcctgagcaccctgccccag-3Ј, 5Ј-cgcggatccgctgcccctggccagaaggtg-3Ј, and 5Ј-cgcggatccgacatcttaacgcggcacttcac-3Ј, and AurB(Ϫ) reverse oligonucleotide. The hemaglutinin (HA)-Aurora B constructs were built by cloning the restricted fragments BamHI-XhoI containing the full-length coding sequence of Aurora B or the amino-terminal deleted coding sequence of Aurora B into the HApCDNA3(ϩ) (Invitrogen, Carlsbad, CA). The resulting HA tag resides at the NH 2 -terminal of the Aurora B constructs.
siRNA Nondegradable Aurora B. Seven mutations were introduced in the region of Aurora B HA-tagged construct that was complementary to the siRNA by site-directed mutagenesis by using the following primers: (AurB7(ϩ), 5Ј-gtcctccggaaGgaAccAgtAacTccTtcGgcacttgtc-3Ј and AurB7(Ϫ), 5Ј-gacaagtgcCgaAggAgtTacTggTtcCttccggaggac-3Ј. The substituted nucleotides are indicated with capital letters.
siRNA Nondegradable Aurora B with Deletion of Amino Acids 7-11 (Aurora-B*). Amino acids 7-11 of the HA-tagged siRNA nondegradable clone of Aurora B were deleted by site-directed mutagenesis by using the primers AurB⌬7-11ϩ (5Ј-gatccgcccagaaggagaactacggccgacagacggctcc-3Ј) and AurB⌬7-11Ϫ (5Ј-ggagccgtctgtcggccgtagttctccttctgggcggatc-3Ј).
pcDNA-HA Dead Kinase Aurora-B*. The kinase inactive mutant of Aurora B, pcDNA-HA Dead Kinase Aurora-B*, was made by site-directed mutagenesis of the pcDNA-HA-Aurora-B*described above. The critical lysine (K) at position 106 was substituted by alanine (A) by using the primers AurBK/Aϩ (5Ј-gccatttcatcgtggcgctcGCTgtcctcttcaagtcccagatag-3Ј) and AurBK/AϪ (5Ј-ctatctgggacttgaagaggacAGCgagcgccacgatgaaatggc-3Ј).
pcDNA-HA-Carboxyterminal-Deletion-Aurora-B* Constructs. The three constructs were obtained using QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) by using three pairs of oligonucleotides: 5Ј-g a a c g g c tg c c c c t g g c c c a g g t c t c a g c c c a c c c t t g g t g a c t c g a g t c-3Ј/5Ј-g a c tc g a g t c a c c a a g g g t g g g c t g a g a c c t g g g c c a g g g g c a g c c g t t c-3Ј, 5Ј-c t t g g g t c c g g g c c a a c t c t t g a c t c g a g t c t a g a g g g c c c g-3Ј/5Ј-c g g g c c c t c t a g a c t c g a g t c a a g a g t t g g c c c g g a c c c a a g -3Ј, and 5Ј-c g g g c c a a c t c t c g g a g g t g a c t c g a g t c t a g a g g g c c c g-3Ј/5Ј-c g g gc c c t c t a g a c t c g a g t c a c c t c c g a g a g t t g g c c c g-3Ј on the pcDNA-HA-Aurora-B* matrix.
The internal deletion HA-Aurora-B ⌬326-333 was obtained using QuikChange site-directed mutagenesis kit with the following pair of primers, 5Ј-ccaggtctcagcccacccttgggtgctgcctccctctgcccttc-3Ј/5Ј-gaagggcagagggaggcagcacccaagggtgggctgagacctgg-3Ј, on the pcDNA-HA-Aurora-B* matrix.
pcDNA-HA-AuroraA1-133-AuroraB78-345 Construct. A PCR fragment corresponding to the amino terminal part of Aurora A was amplified using the AurA(ϩ) 5Ј-cgcggatccgaccgatctaaagaaaactg-3Ј and the chimeric AurAAurB(Ϫ) 5Ј-ggacgcccaatctcaaagtcttccaaagcccactgcctc-3Ј oligonucleotides. A PCR fragment corresponding to the kinase domain of Aurora B was amplified using the chimeric AurA-AurB(ϩ) 5Ј-gaggcagtgggctttggaagactttgagattgggcgtcc-3Ј and the AurB(Ϫ) oligonucleotides. An overlapped PCR product was amplified using both PCR fragments and AurA(ϩ) and AurB(Ϫ) oligonucleotides and cloned into the BamHI and XhoI sites of pcDNA-HA vector.
pcDNA-HA-AuroraA1-133-AuroraB78-326-AuroraA383-403 Construct.First step: pcDNA-HA-AuroraA1-133-AuroraB78-344 construct. A PCR fragment corresponding to the N-terminal part of Aurora A was amplified using AurA(ϩ) (5Ј-cgcggatccgaccgatctaaagaaaactg-3Ј) and chimeric AurA-AurB(Ϫ) (5Ј-ggacgcccaatctcaaagtcttccaaagcccactgcctc-3Ј) oligonucleotides. A PCR fragment corresponding to the kinase domain and C terminal part of Aurora B was amplified using chimeric AurA-AurB(ϩ) (5Ј-gaggcagtgggctttggaagactttgagattgggcgtcc-3Ј) and AurB(Ϫ) (5Ј-ccgccgctcgagggccgacagattgaagggc-3Ј) oligonucleotides. An overlapped PCR product was amplified using both PCR fragments and AurA(ϩ) and AurB(Ϫ) oligonucleotides and cloned into the BamHI and XhoI sites of pcDNA-HA vector.
Second step: pcDNA-HA-AuroraA1-133-AuroraB78-326-AuroraA383-403 construct. A PCR fragment corresponding to the C-terminal part of Aurora A was amplified using chimeric ABA(ϩ) (5Ј-ggtctcagcccacccttggatcacagcaaattcatcaaaacc-3)Ј and AurA(Ϫ) (5-ccgccgctcgagagactgtttgctagatgattc-3Ј) oligonucleotides. A PCR fragment corresponding to AuroraA1-133-AuroraB78-326 was amplified using AurA(ϩ) (5Ј-cgcggatccgaccgatctaaagaaaactg-3Ј) and chimeric ABA(Ϫ) (5Ј-ggttttgatgaatttgctgtgatccaagggtgggctgagacc-3Ј) oligonucleotides. An overlapped PCR product was amplified using both PCR fragments and AurA(ϩ) and AurA(Ϫ) oligonucleotides and cloned into the BamHI and XhoI sites of pcDNA-HA vector. The construct pcDNA-HA-Aurora A 1-333-Aurora B 78-313-Aurora A 370-403 (Figure 8 ) was obtained with the same strategy.
siRNA Preparation
Single-stranded Aurora B gene-specific sense (GAAAGAGCCUGUCAC-CCCAUC) and antisense (AUGGGGUGACAGGCUCUUUUCCG) RNA oligomers were synthesized using 2Ј-O-(tri-isopropyl)silyloxymethyl chemistry (Qiagen S.A., France). Double-stranded RNA was obtained following the manufacturer's instructions. We also used the pSUPER mammalian expression vector that directs the synthesis of siRNA-like transcripts for suppression of Aurora B expression. Two 64-mer oligos, one forward (GATCCCCG-AGCCTGTCACCCCATCTGTTCAAGAGACAGATGGGGTGACAGGCTCT-TTTTGGAAA) and one reverse (AGCTTTTCCAAAAAGAGCCTGTCACCC-CATCTGTCTCTTGAACAGATGGGGTGACAGGCTCGGG) were synthesized (Sigma-Aldrich, St. Louis, MO), annealed, phosphorylated, and ligated into the BglII and HindIII restriction sites of digested pSUPER vector (Brummelkamp et al., 2002) .
Cell Culture, Transfection, and Immunofluorescence Microscopy
HeLa cells were grown on DMEM (Invitrogen) supplemented with 10% fetal bovine serum (Hyclone Laboratories, Logan, UT) and were grown on poly-d-lysine (Sigma-Aldrich)-coated 12-mm-diameter glass coverslips for at least 24 h before transfection. Cells were transfected with 7 g of the different pcDNA Aurora B constructs (encoding HA fusion proteins) by using Lipofectamine 2000 reagent (Invitrogen) according to manufacturer's protocols. Single-stranded sense and antisense strands, used as controls, and siRNA duplexes were introduced into the cells using Oligofectamine (Invitrogen). For double plasmid transfections (pSUPERmediated siRNA and pcDNA Aurora B constructs), 5 g of each plasmid was introduced using Lipofectamine. Routinely, cells 48 h after transfection were fixed with 2% paraformaldehyde in phosphate-buffered saline (PBS) for 20 min at 37°C. Cells before staining were permeabilized with 0.2% Triton X-100 in PBS for 3 min and then incubated with primary and secondary antibodies.
Endogenous Aurora B was detected by monoclonal AIM-1 antibody (BD Transduction Laboratories, Lexington, KY) used at 100-fold dilution, and by a rabbit polyclonal peptide antibody to N-terminal peptide (amino acids 1-17) of human Aurora B (Crosio et al., 2002) used at 500-fold dilution; ectopically expressed HA-Aurora B was detected by anti-HA monoclonal antibody (mAb) (Babco, Richmond, CA) used at 1500-fold dilution. JH human autoim-mune serum (Andreassen et al., 1991) and rabbit polyclonal anti-survivin (Novus Biological, Littleton, CO) were used at 500-fold dilution to detect TD-60 and survivin, respectively. Phosphorylated H3 was detected with phospho-specific polyclonal antibodies to serine 10 and to serine 28 (both from Upstate Biotechnology, Lake Placid, NY) at 500-fold dilution each. Monoclonal IAK1 antibody (BD Transduction Laboratories) recognizing the N terminus of Aurora A was used at 100-fold dilution. Secondary antibodies, including fluorescein isothiocyanate-conjugated affinity-purified goat antimouse and anti-rabbit antibodies, and rhodamine-conjugated antihuman antibodies, were used at 250-fold dilution (all from Jackson ImmunoResearch Laboratories, West Grove, PA). An Alexa Fluor 568-conjugated goat antirabbit antibody (Molecular Probes, Eugene, OR) also was used at 250-fold dilution. DNA was detected by incubation with 0.2 g/ml propidium iodide in PBS for 5 min after incubations with secondary antibodies. Images were collected with an MRC-600 laser scanning confocal apparatus (Bio-Rad, Hercules, CA) coupled to a Nikon Optiphot microscope.
Cell Extracts and Immunoblotting
Twenty-four hours after transfection, cells were blocked in mitosis for additional 24 h in the presence of 0.1 g/ml nocodazole (Sigma-Aldrich). Mitotic cells were harvested by mitotic shake off and lysed in SDS 1ϫ sample buffer containing 6 M urea. Lysates were boiled, sonicated, and loaded onto polyacrylamide gels and then transferred to nitrocellulose. Endogenous Aurora B was detected by AIM-1 mAb (BD Transduction Laboratories) and anti-Aurora B N-terminal peptide antibody and ectopically expressed HA-Aurora B with an anti-HA mAb (Babco). Nitrocellulose sheets were then incubated with horseradish peroxidase-conjugated goat anti-mouse and anti-rabbit IgG secondary antibodies. Protein-antibody complex was detected by enhanced chemiluminescence (Pierce Chemical, Rockford, IL).
RESULTS
In agreement with the previous observations, we have found that human Aurora B kinase, expressed as a HA-tagged chimera, exhibits a distribution pattern typical of passenger proteins in HeLa cells ( Figure 1A ). At metaphase, Aurora B kinase was present on centromeres ( Figure 1A ) where it colocalized with other passenger proteins ( Figure 3 ). As mitosis proceeded through anaphase, Aurora B dissociated from centromeres and accumulated at the cleavage furrow and the midbody (Bischoff et al., 1998; Terada et al., 1998; Crosio et al., 2002) . By contrast, HA-tagged Aurora A localized to the centrosomes and to the mitotic spindle, as observed previously (Gopalan et al., 1997; Kimura et al., 1997; Bischoff et al., 1998; Crosio et al., 2002) . It is important to note that the localization observed occurs in the context of overexpression of HA-tagged protein. We have observed no difference in localization relative to native protein, nor interference in function with overexpressed protein.
The distinct localization and functions of Aurora A and Aurora B must be dictated by differences in sequence. For reference, we show sequence alignment between the two human kinases ( Figure 1B) , with identical sequences highlighted in yellow. Both the N-terminal and C-terminal regions of the two proteins contain divergent sequences, whereas the central catalytic domain has a high degree of homology. Our purpose has been to determine the sequence within Aurora B that defines its unique localization and function.
As has been observed previously (Ditchfield et al., 2003; Hauf et al., 2003) , treatment with siRNA resulted in a strong decrease in Aurora B content in mitotic cells, as determined by immunofluorescence analysis ( Figure 2A ) and by Western blots ( Figure 2B ). At 48 h posttransfection, 46 Ϯ 1% of all mitotic cells were negative for Aurora B ( Figure 2C ), and suppression persisted to 72 h. Aurora B-depleted cells exhibited several mitotic defects, including metaphase misalignment and missegregation of chromosomes, characterized by lagging chromatids during anaphase (Figure 2A ). At 72 h posttransfection, 77 Ϯ 1% of all mitotic cells negative for Aurora B were in prometaphase compared with 18 Ϯ 4% of Aurora B-positive cells. Despite its reported role in histone H3 phosphorylation (Adams et al., 2001b; Giet and Glover, 2001 ), Aurora B depletion had no detectable effect on chromosome condensation: the compactness of mitotic chromosomes in Aurora B-silenced cells seemed very similar to the state of chromosomes in nontransfected cells.
As expected from previous work (Adams et al., 2001b; Hauf et al., 2003) , the ablation of Aurora B resulted in a dramatic increase in polyploidy, as assayed by the presence of binucleate and multinucleate cells. At 72 h posttransfection, 28 Ϯ 4% of the total cell population versus 3% of the untreated cells were multinucleated. In addition, treatment with siRNA affected the prometaphase-metaphase transition, yielding a significant increase of the percentage of mitotic cells at prometaphase in transfected cells in comparison with control nontransfected cells.
Ectopic Replacement of Aurora B and Restoration of Aurora B Function
Absence of localization of Aurora B may indicate a reduced affinity for binding sites rather than an absence of function. In this case, correct localization and function can be restored in the absence of the competing wild-type protein. We have thus coupled depletion of the endogenous Aurora B with siRNA treatment and expression of mutant Aurora B within the same cell ( Figure 2D ), in a "pseudogenetics" approach. Briefly, taking advantage of the degenerate genetic code, we have made both "wild-type" and truncation mutant Aurora B HA-tagged cDNA constructs that could not be suppressed by siRNA treatment (see Materials and Methods). In addition, to separately detect either endogenous or ectopically expressed Aurora B in the same cell, a sequence of five amino acids (7-11) was deleted from the N terminus of each of these HA-tagged constructs. Such mutants that are silent for the Aurora B N-terminal antibody (Crosio et al., 2002) are referred to as "Aurora B*." We were thus able to detect the endogenous kinase by using an anti-peptide antibody that specifically recognized the five-amino acid sequence (7-11) of the N terminus of Aurora B, both by Western blot ( Figure  2E ) and by immunofluorescence ( Figure 2F ). In contrast, the antibody did not recognize ectopically expressed wild-type kinase (Aurora B*), because these five amino acids were deleted from the sequence (Figure 2 , E and G). Instead, the ectopically expressed protein was detected with an anti-HA antibody (Figure 2 , E and G). Note that the rhodamine secondary antibody used to detect the N-terminal epitope in Figure 2G recognized a nonspecific antigen at the cell cortex. Despite this nonspecific signal, the N-terminal antibody did not localize to chromosomes or to the midbody. No cortical stain was seen with the same primary antibody visualized with a fluorescein-coupled secondary antibody ( Figure 2F ).
These results permitted cotransfection with both siRNA and HA-tagged Aurora B* to rescue function. In such cotransfection experiments, the ectopically expressed wildtype Aurora B* localized properly in siRNA-treated cells, whereas no signal was observed by the N terminus antipeptide antibody, demonstrating an efficient ablation of the endogenous Aurora B in the same cells ( Figures 2G and 3B) .
Importantly, the overexpression of the wild-type Aurora B* in the siRNA-treated cells completely reversed the siRNA phenotype, restoring correct chromosome alignment. Thus, 46% of all mitotic double-transfected cells were aligned in metaphase, whereas 75% of cells transfected with siRNA alone were in prometaphase. Cell cleavage was also normal ( Figure 3B ), and consequently mononucleate cells were maintained at levels comparable with controls that were not treated with siRNA. Thus, 5 Ϯ 2% of double-transfected cells were multinucleated versus 3 Ϯ 3% of controls at 48 h.
Overexpression of Aurora B* ( Figure 2E ) was not of consequence to the rescue phenotype. Localization of the rescue protein was correct, and restoration of function was complete, both with respect to induction of correct localization of other passenger proteins and restoration of Aurora B function both at metaphase and during cell cleavage.
siRNA silencing of Aurora B severely disturbed the distribution pattern of the passenger proteins survivin and Figure 3A) . Additionally, survivin and TD-60 were perturbed in distribution during anaphase, and did not quantitatively transfer to the central spindle as in control cells but remained largely associated with the chromosomes ( Figure 3A) . These results are in agreement with the available data for the redistribution of the passenger proteins survivin and INCENP in other systems after depletion of Aurora B (Kim et al., 1999; Kaitna et al., 2000; Speliotes et al., 2000; Adams et al., 2001a; Tanaka et al., 2002; Carvalho et al., 2003) and suggest that mammalian Aurora B could be a required structural component of a passenger protein complex.
In contrast to siRNA-transfected cells, Aurora B, survivin, and TD-60 all localized correctly both to centromeres at metaphase and to the spindle midzone in rescued cells (Figure 3B) . Thus, in keeping with a rescue phenotype, the distribution of the passenger proteins in rescued cells was indistinguishable from that of the control cells ( Figure 3B ). Therefore, we conclude that the expressed exogenous kinase Aurora B* can functionally replace the endogenous Aurora B. These results have validated our approach and have permitted us to study the effect of the kinase mutants in a background where endogenous Aurora B is absent.
Expression of Aurora B N-Terminal Truncation Mutants and Their Effects on Mitosis in the Absence of Endogenous Protein
Having established that ectopically expressed Aurora B could functionally replace endogenous Aurora B that had been suppressed by siRNA transfection, we were able to conduct experiments in which wild-type Aurora B would be replaced by truncation mutants. The N-terminal (1-66) residues of Aurora B are highly divergent from the termini of Aurora A (Figure 1 ), which has a mitotic localization and function that is distinct from Aurora B. We therefore con- were introduced by site-directed mutagenesis, in the region complementary to the siRNA, in an HA-tagged Aurora B construct without affecting the Aurora B amino acid sequence. Then, a sequence of 15 nucleotides of this new construct, corresponding to the amino acids 7-11 of the N terminus of Aurora B, was deleted (indicated by ⌬7-11). This created a form of Aurora B (Aurora B*) that could not be degraded by siRNA, and whose expression could only be detected by an anti-HA antibody, but not by the antibody to the N terminus of the endogenous protein. Endogenous Aurora B was visualized by an anti-peptide antibody raised against the amino acid sequence 1-17 of the N terminus of Aurora B. Amino acid sequence 7-11 of the N terminus of Aurora B was crucial for the recognition of the kinase by the antibody. The double blue bar indicates siRNA, which either can or cannot interact with the message, as indicated. (E) The antibody raised against the amino acid sequence 1-17 of the Aurora B N terminus (anti-N-term) recognizes only Aurora-B kinase with an intact N terminus. Because Aurora B* lacks the 7-11 amino acid sequence, this form of the kinase could not be detected by the anti-N-terminus antibody. HA-Aurora B and HA-Aurora B* were ectopically expressed in HeLa cells and detected by Western blot by using the anti-N-terminus (anti-N-term) and anti-HA antibodies. Arrows indicate the ectopically expressed and the endogenous kinases. Lanes are labeled to indicate Aurora B or Aurora B* expression. (F) Immunofluorescence microscopy detection of the distribution of endogenous Aurora B in HeLa cells by using the anti-N-terminus antibody; PI, propidium iodide. (G) Rescue of normal chromosome alignment and cytokinesis in Aurora B siRNA-treated HeLa cells cotransfected with HA-Aurora B*. Note the complete absence of endogenous Aurora B kinase as seen by the absence of staining by the anti-N-terminus antibody (anti-N-term) at Aurora B sites stained with HA-antibody (red in merge). The rhodamine secondary antibody used with anti N-term primary gave a nonspecific cortical stain. Bar, 5 m. First, we determined the effect of overexpression of the different truncation mutants in mitotic cells alone, without suppression of the endogenous protein. Expression of these different truncation mutants in HeLa cells that retained native Aurora B demonstrated that N-terminal truncation mutants of Aurora B were neither displaced from centromeres at prometaphase/metaphase nor from the spindle midzone during anaphase ( Figure 4A ). Furthermore, none of these mutants had a dominant negative effect on karyokinesis or cytokinesis in the presence of native Aurora B. We then determined the effect of expression of the truncation mutants in the absence of endogenous wild-type Aurora B. Controls in this experimental series showed, as in previous figures, that Aurora B was absent from centromeres in siRNA-transfected mitotic cells and that survivin and TD-60 were both dispersed from metaphase chromosomes (data not shown).
Replacement of native Aurora B by the N-terminal truncation mutant, Aurora B*⌬N 1-66, was without consequence for localization of Aurora B to centromeres or to the spindle midzone and did not interfere with normal completion of cell cleavage ( Figure 4B ). Furthermore, both survivin and TD-60 localized correctly to the centromeres at metaphase and to the spindle midzone during cell cleavage in Aurora B*⌬N 1-66 -expressing cells.
Substitution of the N-Terminal Region of Aurora B by Aurora A Sequence Does Not Alter Aurora B Localization or Function
The lack of effect of the absence of the N terminus of Aurora B on its localization or function permitted us to address whether the divergence of sequence in the N terminus between Aurora A and B derived from a specific N-terminal sequence requirement for correct localization of Aurora A. We tested this possibility by replacing the Aurora B N terminus with the N terminus of Aurora A, creating an HA-tagged chimera, Aurora A 1-133-Aurora B 78-344 (Figure 5A) .
The chimeric protein clearly localized to centromeres at metaphase and to the spindle midzone during cell cleavage ( Figure 5A ) and did not interfere with the proper completion of cleavage. Importantly, the chimera did not localize to centrosomes. Antibody to the N terminus of Aurora A con- firmed that N-terminal Aurora A sequence was present both at centrosomes and at centromeres at metaphase and at centrosomes and the spindle midzone during cell cleavage ( Figure 5B ). This result demonstrated that the chimera did not interfere with normal Aurora A association with centrosomes and that the chimeric protein specifically failed to localize to centrosomes.
The correct localization of Aurora A 1-133-Aurora B 78-344 to centromeres and to the spindle midzone, and the apparently normal cleavage observed when Aurora B was replaced by this mutant, suggested that the N terminus of Aurora A did not interfere with correct localization of passenger proteins to the centromere or to the spindle midzone. We confirmed this possibility by observing the distribution of survivin and of TD-60 in cells cotransfected with siRNA to Aurora B and with cDNA for Aurora A 1-133-Aurora B 78-344. The distribution of the other passenger proteins was normal in all respects ( Figure 5C ), both at metaphase (left images) and at anaphase/telophase (right images).
A Specific C-Terminal Region of Aurora B, Amino Acids 326-333, Is Required for Localization and Function
The N-terminal sequence divergence between Aurora B and Aurora A is not determinant for the distinct localization of Aurora B. We therefore focused on determining the effect of C-terminal Aurora B truncations or internal deletion on Aurora B localization and function.
After C-terminal truncation of the sequence divergent from Aurora A (⌬333-344), Aurora B correctly localized both to kinetochores and to the anaphase spindle bundle, either with or without ablation of native Aurora B ( Figure 6A ). In contrast, further deletion of the C terminus (⌬331-344 and ⌬326 -344) caused failure to localize in the presence of the native protein, and the ectopic Aurora B was completely dispersed in mitotic cells (Figure 6 , B and C, left images). Despite its displacement, the C-terminal truncation mutant had no dominant negative effect on chromosome congression or on cytokinesis.
Despite the mislocalization of Aurora B ⌬331-344 in the presence of native protein, it correctly localized and substituted for Aurora B after ablation of the native protein (Figure 6B, right) , suggesting weaker affinity for binding sites, but retention of function in the absence of the native protein.
In the presence of these mutants, the other passenger proteins correctly localized ( Figure 6, A and B) . In contrast ⌬326-344 did not substitute for native Aurora B after siRNA ablation ( Figure 6C ), and cells could not proceed past prometaphase/metaphase. Furthermore, the passenger proteins survivin and TD-60 were dispersed as well. These results suggested that residues 326 -333 were critical for Aurora B function. We therefore tested the function of Aurora B containing an internal ⌬326-333 mutation. This mutant was completely defective in localization in the presence of the native protein ( Figure 6D, left) , and when substituted for ablated native Aurora B, it could not localize or rescue function. No HA-positive cells were observed to progress past metaphase, and the other passenger proteins dispersed throughout the chromosomes. Our results indicate that the C-terminal region is critical for Aurora B localization to centromeres and also indispensable for the localization of other passenger proteins. The C-terminal region also seems essential for progression past metaphase.
All Aurora B C-Terminal Truncation Mutants Exhibit Histone H3 Kinase Activity
We have found that rescue with the ⌬326-344 and the ⌬326-333 mutants of Aurora B results in failure of chromosome localization and of progression past metaphase. Although this seems to identify an important functional region of Aurora B, we needed to eliminate the possibility that failure of rescue was due instead to disrupted folding of the enzyme and global failure of function. Careful analysis of the putative Aurora B structure, based on Swiss model alignment with comparable sequence in the Aurora A structure, showed that residue 326 should lie outside the core structure of the enzyme, beyond the last alpha helix, and would be unlikely to be important to structural integrity (our unpublished data).
To confirm this impression, we conducted an analysis of the capacity of the Aurora B mutants to properly phosphorylate two residues on histone H3 (S10 and S28), which are Aurora B substrates (Hans and Dimitrov, 2001; Goto et al., 2002) . Aurora B siRNA-transfected cells were rescued with different Aurora B mutant constructs, as described above, and mitotic cells were assayed 48 h posttransfection for the presence of the phosphoepitopes for S10 ( Figure 7A ) and S28 ( Figure 7B ) on histone H3. As a control, in addition to the C-terminal deletion constructs cells were also rescued with an Aurora B active site point mutant (K106A) that totally suppresses kinase activity (Terada et al., 1998) . The result clearly demonstrated that all C-terminal mutant constructs retained the capacity to phosphorylate both histone H3 phosphoepitopes in contrast to the K106A mutant, which localized correctly to kinetochores but failed to generate histone H3 phosphoepitope signals in transfected cells (Figure 7) .
Rescue with Double N-and C-Terminal Chimeras of Aurora A and Aurora B
Sequence comparison between Aurora B and Aurora A indicates that three of seven residues are identical in the critical 326 -333 region of Aurora B ( Figure 1B) . We therefore asked whether the C-terminal sequence of Aurora A could substitute for the C-terminal sequence of Aurora B to restore function. The chimera containing N-terminal Aurora A sequence and C-terminal Aurora B sequence (Aurora A 1-133-Aurora B 78-344), as described in Figure 4B , was further modified by a C-terminal tail swap of Aurora A sequence (370 -403) for aligned . This chimera did not localize either to kinetochores during early mitosis nor to the spindle midzone in anaphase (Figure 8) . Remarkably, however, the chimera rescued both localization and function in cells where the native Aurora B had been ablated by siRNA (Figure 8, bottom) . We chose a sequence for exchange that included divergent Aurora B sequence upstream of residue 326 (see alignment in Figure 1B ) to assay for the broadest possible effect of C-terminal exchange. The same experiment also was conducted with a tail swap of Aurora A sequence 383-403 for Aurora B sequence 326 -344, with results comparable with the longer swap (data not shown). We conclude that a small stretch of the C-terminal region from residue 326 -333 is critical to Aurora B function, and that the C terminus of Aurora A contains sequence with the latent capacity to substitute for Aurora B function in the absence of native Aurora B.
DISCUSSION
We have conducted a molecular genetic analysis of the function of domains within the primary sequence of Aurora B. Our approach combines the suppression of wild-type Aurora B by siRNA with the overexpression of truncation or domain replacement mutants within the same cell. These mutants were engineered so that they would not be sup- pressed by siRNA. Furthermore, rescue could be confirmed both by the absence of Aurora B antigen and the presence of an HA-tag. This condition was created by mutation of the cDNA so that the replacement form of Aurora B did not contain the antigenic site recognized by the antibody against wild-type Aurora B. Controls demonstrated that both suppression of endogenous Aurora B, and its rescue by ectopic normal Aurora B, are successful. With this approach, we have demonstrated that the C-terminal region of Aurora B is critical to Aurora B localization and function during cell division. Surprisingly, the homologous region of Aurora A, although divergent, could rescue Aurora B localization and function.
Demonstration of the Important Targeting Role of the C Terminus of Aurora B
The Aurora B catalytic domain is highly homologous in sequence to the catalytic domain of Aurora A, but Aurora B contains an N-terminal domain that diverges substantially from Aurora A sequence. Sequence alignment shows that the divergent N termini of human Aurora A and Aurora B contain 132 residues and 75 residues, respectively. Aurora A and B also have short divergent C-terminal tails, consisting of 16 residues in human Aurora A and 13 in human Aurora B. Aurora B is targeted to centromeres and to the spindle midzone during mitosis, whereas Aurora A associates with the centrosome and with the mitotic spindle. These distinct sites of localization undoubtedly are important elements of the discrete functions of the different Aurora kinases.
Aurora A is required for centrosome maturation and formation of a bipolar mitotic spindle, whereas Aurora B is required for proper chromosome segregation in mitosis and for cell cleavage during cytokinesis. Because the majority of the Aurora kinase sequences are highly homologous, it was reasonable to assume that the unique N-terminal sequences were responsible for discrete targeting and therefore for the unique functions of the two kinases. Our results have surprisingly established that this is not the case.
Prior evidence had suggested that the Aurora A N terminus may have a targeting role in Xenopus (Giet and Prigent, 2001) . It was therefore a surprise to find that ablation of the N terminus of Aurora B was without consequence for its correct localization to both centromeres and to the spindle midzone during mitosis. Furthermore, when native Aurora B was suppressed by siRNA and replaced by N-terminal truncation mutants, the ectopic protein completely mimicked normal Aurora B localization and fully restored Aurora B mitotic function. We have eliminated an alternative explanation that although the N-terminal-truncated Aurora B cannot localize by itself, it may dimerize with residual native Aurora B and arrive passively at the correct sites. Although it is unlikely that we have eliminated all of native Aurora B from transfected cells, this is not likely the case. First, the native form is not evident at the proper locations in rescued cells, whereas the rescue constructs localize correctly ( Figure 2G ). Second, if it occurred, dimerization should have permitted phosphorylation of histone H3 when cells were rescued with the Aurora B dead kinase mutant, but this was not the case (Figure 7) .
Our results thus demonstrate without equivocation that the N-terminal divergent sequence of Aurora B has no role in targeting or function in mitosis. Furthermore, it is noteworthy that absence of the N terminus of Aurora B had no effect on correct localization of the other passenger proteins. The N terminus of Aurora B therefore may not play a crucial role in the formation of the passenger protein complex during mitosis as has been proposed for Xenopus Aurora B (Bolton et al., 2002) .
Having established that the N terminus of Aurora B was without apparent function, we could test the effect of swapping the N terminus of Aurora A in place of the N terminus of Aurora B. If the N terminus of Aurora A had such an addressing function in mammalian cells, the chimeric protein should have been recruited exclusively to the centrosomes, or to the centrosomes in addition to the centromeres. In fact, we found no evidence for the recruitment of the Figure 7 . Intracellular kinase activity of the different Aurora B deletions and kinase-dead mutant in the absence of endogenous Aurora B. Cells were cotransfected with siRNA and the various constructs of Aurora B. Cells were than prepared for double immunofluorescence by using anti-HA and H3 phosphospecific antibodies to S10 (A) and S28 (B). Although the HA-AurBK106A mutant localizes to kinetochores, there is almost a complete loss of H3 S10 and H3 S28 phosphorylation. In contrast, H3-S10 and H3-S28 phosphorylation is rescued by the wild-type and all C-terminal deletion mutants of Aurora B irrespective of their ability to associate with the kinetochores. All H3 phosphorylation images were recorded at the same confocal microscope settings. chimeric protein to centrosomes, and the presence of the N terminus of Aurora A did not influence the localization or function of the ectopic Aurora B chimera in experiments where it replaced the endogenous Aurora B, nor, interestingly, did the chimera alter the targeting of native Aurora A to centrosomes ( Figure 5B ). It is possible that the targeting efficiency of the Aurora A N terminus is relatively weak and it cannot effectively alter the affinity of the remainder of Aurora B for the centromeres at metaphase or the spindle midzone in anaphase.
Truncation and rescue experiments also have established that the sequence in the C terminus of Aurora B that diverges from Aurora A is similarly without effect on localization. The results are a little more complex than those with the N-terminal truncations and chimeras. Truncation of the C-terminal region to amino acid 333 does not disturb localization or function in the presence or absence of native Aurora B. Interestingly, the loss of two arginines (⌬331-344) by further truncation causes a loss of binding of Aurora B to kinetochores and to the midbody in the presence of native Aurora B. However, after ablation of the endogenous protein, this mutant localizes correctly and restores function. These results suggest strongly that this near C-terminal sequence plays a role in correct localization and function and contributes to the affinity of Aurora B for its binding sites.
Further truncation to amino acid 326 leads to loss of recruitment of Aurora B either in the presence or absence of endogenous protein. This mutant additionally does not restore Aurora B function. We have eliminated the possibility that these truncation mutants are massively denatured and do not localize for this reason. The mutants retain native kinase activity toward the well recognized Aurora B substrate histone H3, and these results contrast strongly with the suppression of phosphorylation of histone H3 upon rescue of Aurora B ablation with a dead kinase mutant. Furthermore, structural modeling suggests the truncations Figure 8 . Intracellular localization of an Aurora A-Aurora B chimera with C-terminal Aurora A sequence, and its restoration of Aurora B function in siRNA-transfected cells. Localization and function of the Aurora A-Aurora B (AurA1-133-AurB78-313-AurA370-403) chimera alone, and in rescue of Aurora B siRNA-transfected cells. The scheme of the construct is shown on top of the images. The Aurora B domain is blue, whereas Aurora A domain swaps are shown in gray. Lack of kinetochore and spindle midzone localization of the HA-Aurora B chimera containing N-(1-133) and C-terminal residues (370 -403) of Aurora A (top) in prometaphase (prometa), metaphase (meta), or telophase (telo) cells. Forty-eight hours after transfection cells were stained with anti-HA and with propidium iodide (PI). In constrast, HeLa cells contransfected with siRNA for Aurora B and with plasmid expressing the AurA1-133-AurB78-313-AurA370-403 chimera (bottom) showed complete restoration of localization and function, and correctly colocalized with other passenger proteins. Cells were stained with anti-HA, with anti-survivin or with human JH autoimmune serum, recognizing TD-60, and counterstained with PI. The upper and lower images are recordings of the same cell in two channels. Bar, 5 m.
The C Terminus Targets Aurora B Vol. 16, January 2005 performed are in an unstructured tail domain of Aurora B that should not contribute to the overall protein structure.
These results thus illustrate that the sequence 326 -333 is essential for localization and function of Aurora B. The two arginines (332, 333) seem important for binding affinity at the kinetochore and the midbody. Our rescue results indicate that the sequence content in this near C-terminal domain, aside from a potential role for the two arginines, is not of consequence for its localization, as a complete replacement of (⌬313-344) by the C terminus of Aurora A restores both localization and function in cells depleted of endogenous Aurora B, a result parallel to that with the ⌬331 mutant. Our results thus establish that the latent capacity exists in Aurora A C-terminal sequence to restore Aurora B truncation mutants to normal localization and function. It will be of substantial interest, in this context, to perform similar ablation and mutant rescue experiments with Aurora A to define its localization requirements in the context of sequence divergence from Aurora B.
